Medical Society of Delaware Academic Channel

The Medical Society of Delaware no longer publishes a printed scientific journal (the Delaware Medical Journal) and has launched an online Academic Channel on the website of the Cureus Journal of Medical Science

Members are invited to review the Medical Society of Delaware Academic Channel and consider submitting original research, review articles, case reports, or technical reports for publication.  Guidelines to submitting articles through the MSD Academic Channel have been created to help better understand the process and how authors are more engaged in the submission and review procedure.

A separate Digital Digest will also be published and distributed via email to members every several months, delivering information about published articles on the Channel, as well as other educational information that was posted.

If you would like to join the team of peer reviewers for the Academic Channel and be part of the Cureus community, please contact Mary LaJudice (or call 302/224-5183) for more information.

Delaware Medical Journal Archives

Submit an Article

It is highly recommended to review the Guidelines for submitting articles through the MSD Academic Channel document and familiarize yourself with the Author Instructions before starting the submission process.

Advertise on the
MSD Academic Channel

Advertising is not being formally accepted at this time while we work to build the MSD Academic Channel. If you are interested in advertising, please contact Mary LaJudice (302/224-5183).

Delaware Medical Journal Archives

Press Releases & Official Statements





Fentanyl, Stimulants, Hallucinogens and Other substances
Dear Members: This is the third in a series of communications to provide a summary of the topics discussed at the American Medical Association (AMA) State Advocacy Summit (SAS), which I attended at the beginning of this year. The meeting was packed with enlightening information on a list of topics from a variety of panelists that I want to share with you. The third in my series of communications from the AMA State Advocacy Conference is a discussion on "Fentanyl, Stimulants, Hallucinogens, and Other Substances." There was a very good panel at the State Advocacy Summit on fentanyl, stimulants, hallucinogens, and other substances which have had a devastating impact on in our communities. Read more.


Scope of Practice (AMA State Advocacy Summit)
Dear Members: This is the second in a series of communications to provide a summary of the topics discussed at the American Medical Association (AMA) State Advocacy Summit (SAS), which I attended at the beginning of this year. The meeting was packed with enlightening information on a list of topics from a variety of panelists that I want to share with you. Read more.


Insurance Barriers to Care, AMA State Advocacy Summit 
Dear Members: I had the opportunity to attend the American Medical Association (AMA) State Advocacy Summit, which concluded in not-so-sunny Amelia Island, Florida. The meeting was packed with enlightening information on a list of topics from a variety of panelists. Because of the importance of these issues, I plan a series of communications to the membership over the next several months with a summary of the topics discussed, as well as my thoughts. Read more. 


eNews and Views Archives

6/6/2024
6/4/2024 - Tilton Award
5/30/2024
5/23/2024
5/28/2024
5/16/2024
5/9/2024
5/7/2024 - Legislative Action Report
5/2/2024
4/30/2024
4/25/2024
4/22/2024
4/19/2024
4/11/2024
4/4/2024
3/30/2024 - Happy Doctors Day
3/21/2024
3/17/2024HHS Briefing on Change Healthcare Cyberattack
3/14/2024
3/11/2024 - Change Healthcare Cyberattack Update 
3/8/2024Change Healthcare Cyberattack Update – Timeline for Restoring Systems
3/7/2023
3/4/2024Change Healthcare Hack; Medicare Pay Cuts
2/29/2024
2/27/2024
2/22/2024
2/15/2024
2/8/2024
2/6/2024
2/1/2024
1/30/2024 - Legislative Update
1/25/2024
1/16/2024 - Delaware Health Care Virtual Town Hall
1/11/2024
1/4/2024